Thermo Fisher Scientific is launching a new test it says can help doctors avoid the “trial-and-error” approach typically used ...

Transformative Biotech has appointed Mark Kelleher, PhD, as Executive Vice President of Research & Development, strengthening the leadership team as it advances its extraction-free PCR platform for ...

The broader markets, represented by the NSE Nifty 500 Index, outperformed the benchmark indices, led by Concord Biotech's 13% rally, followed by Usha Martin's 6% gain.

世界の遺伝子増幅技術市場は、2024年から2032年にかけて、286億米ドルから374億米ドルまでの収益増加が見込まれ、年平均成長率（CAGR）は3％に達すると予測されています。この市場の成長は、遺伝子増幅技術が医療診断、研究、およびバイオテクノロジー分野での応用の増加に伴い、ますます重要性を増していることに起因しています。本記事では、遺伝子増幅技術の概要、用途、成長を支える要因について詳細に解説 ...

Swiss Rockets AG announces that its CoolMPS 600 mid-throughput sequencer with advanced chemistry and novel MPS/NGS read length will become available in Q2 2026. Enabled by its exclusive license of ...

Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a substantial and escalating burden. | Demyelinating diseases, including multiple sclerosis (MS ...

Mass photometry is a fast and powerful tool for adeno-associated virus analytics with single-particle resolution.

NG-TEST® Candida auris is the first rapid lateral flow immunoassay specifically designed to identify C. auris from cultured samples in 15 minutes. Published data demonstrate 100% concordance with ...

NG-TEST®カンジダ・アウリスは、培養検体からC.

SANTA MARIA, Calif. and GUIPRY, France, Feb. 18, 2026 /PRNewswire/ -- In a major step forward against Antimicrobial ...

SANTA MARIA, Calif. and GUIPRY, France, Feb. 18, 2026 /PRNewswire/ -- In a major step forward against Antimicrobial Resistance (AMR), NG Biotech, in partnership with Hardy Diagnostics, announced ...

Here are the latest biotech industry updates: introducing new platforms for SPR, RNA-seq libraries and DNA extraction.